In The News Posted September 4, 2019 Share Posted September 4, 2019 NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ:GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.